首页> 外国专利> CAPSULE FORMULATION COMPRISING MONTELUKAST OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND LEVOCETIRIZINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

CAPSULE FORMULATION COMPRISING MONTELUKAST OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND LEVOCETIRIZINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

机译:包含孟鲁司特或其药学上可接受的盐和左西替利嗪或药学上可接受的盐的胶囊剂

摘要

The present invention relates to a pharmaceutical composition comprising 1) a montelukast independent layer comprising montelukast or a pharmaceutically acceptable salt thereof; And 2) a levocetirizine-independent layer comprising levocetirizine or a pharmaceutically acceptable salt thereof in a separate state, and a method for producing the capsule preparation for preventing or treating allergic rhinitis and asthma. The capsule preparation according to the present invention can completely isolate the two active ingredients, minimizing the reactivity between the active ingredients, so that the stability of the product according to the change with time is excellent and the therapeutic effect can be maximized.
机译:本发明涉及一种药物组合物,其包含1)孟鲁司特独立层,其包含孟鲁司特或其药学上可接受的盐;和和2)单独的包含左西替利嗪或其药学上可接受的盐的左西替利嗪非依赖性层,以及制备用于预防或治疗变应性鼻炎和哮喘的胶囊制剂的方法。根据本发明的胶囊制剂可以完全分离两种活性成分,使活性成分之间的反应性最小化,使得产品随时间变化的稳定性优异,并且可以使治疗效果最大化。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号